A satellite builder won a €1bn order and the stock ended the day flat
A German family-controlled space company just landed the first major contract of Europe's answer to Starlink, days after separately winning a European launcher programme — and the shares still trade below the price professional investors paid for them in June. Two pieces of good news, no net repricing.
Satellite operator SES awarded Bremen-based OHB SE a contract worth close to €1 billion on August 31 to develop and build all 18 satellite platforms for the medium-orbit segment of IRIS2, the European Union’s €15.6 billion secure communications constellation. It is the first major industrial order since the programme entered its implementation phase.
Days earlier, the European Space Agency awarded €186.9 million to Rocket Factory Augsburg — an OHB subsidiary — under its first launcher competition, requiring a flight to orbit before 2028. The shares gained roughly 6-8% on the contract news and gave much of it back. OHB completed a capital increase in June at €300 per share, raising about €482 million and lifting its equity ratio from 27.5% to 43.3%; the stock has recently traded around €233.50, some 22% below that issue price.
Opportunity
Most of Europe’s promising space companies — the launch startups in particular — are private and unbuyable. OHB is one of the few listed ways to hold that exposure, and it just doubled its strategic relevance in a single week, on both the satellite and the launch side. My read: the two standard explanations for a stock ignoring good news do not fit here. The dilution overhang is gone, because the raise completed in June.
And the negative second-quarter operating result was driven by roughly €22.4 million of one-off costs tied to that capital measure rather than by the underlying business. What is left is a company with a materially better backlog trading below the price institutions paid two months ago. That is an inference about why the price has not moved, not a claim about where it goes.
How it could play out
The one-off costs wash out of reported results, and the next set of numbers shows the record backlog without the noise. Further IRIS2 awards follow for the much larger low-orbit segment, where being the incumbent platform supplier matters. If the launcher subsidiary reaches orbit on schedule, a listed company owns one of the few European launch vehicles that works. Any of those would give a thinly-traded stock a reason to be looked at again.
Questions worth asking
- What margin does OHB historically earn as a satellite platform prime? A €1bn political programme at low single-digit margins is a very different asset from a €1bn commercial order.
- Does winning the medium-orbit platforms position OHB for the far larger low-orbit segment still to be awarded, or are those separate competitions with different incumbents?
- How is the launcher subsidiary consolidated, and what would a successful orbital flight actually be worth to the parent?
- Who else is listed and levered to European sovereign space spending, and has any of that group repriced while this one has not?
Where to look
- OHB SE — Frankfurt-listed, family-controlled, thin float; the direct expression and the reason to be careful about size
- SES — the operator awarding the contract and the other listed side of IRIS2
- the European space and defence complex more broadly, as the funding source behind both awards
Thesis check
A near-€1bn order at a company this size is transformative rather than incremental, and the usual reason a stock ignores good news — a pending share sale hanging over it — has already been removed. The constraints are practical: it is a thinly-traded foreign small cap with a controlling family, and European institutional programmes are not always good business, so the order’s margin is the thing that would decide this.
Sources
European Spaceflight, Aug 31 2026 · Defence Industry Europe, 2026